262 related articles for article (PubMed ID: 17464818)
41. [The "Action Woman Health" program in three Lyons suburbs].
Mignotte H; Le Goaziou MF; Nachury LP; Pérol D; Fontaniere B; Fouillat V; Lasset C
Sante Publique; 2000 May; 12 Spec No():45-58. PubMed ID: 10989628
[TBL] [Abstract][Full Text] [Related]
42. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
43. Results of a cervical cancer screening programme from an area of Barcelona (Spain) with a large immigrant population.
Casamitjana M; Sala M; Ochoa D; Fusté P; Castells X; Alameda F;
Eur J Public Health; 2009 Oct; 19(5):499-503. PubMed ID: 19435798
[TBL] [Abstract][Full Text] [Related]
44. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
45. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
46. [Screening profile of women who have died from cervical cancer].
Ejersbo D
Ugeskr Laeger; 2008 Feb; 170(9):727-30. PubMed ID: 18307959
[TBL] [Abstract][Full Text] [Related]
47. Current techniques in screening for cervical cancer in Spain: updated recommendations.
Puig-Tintoré LM; Torné A; Alonso I
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S8-S10. PubMed ID: 18606440
[TBL] [Abstract][Full Text] [Related]
48. [Cervical cancer screening in the Bas-Rhin. Evaluation of four and a half years of the EVE campaign].
Fender M; Schaffer P; Dellenbach P
Sante Publique; 2000 May; 12 Spec No():11-20. PubMed ID: 10989625
[TBL] [Abstract][Full Text] [Related]
49. Cervical cancer screening: A Slovenian experience.
Primic-Zakelj M; Repse-Fokter A
Coll Antropol; 2007 Apr; 31 Suppl 2():23-6. PubMed ID: 17600934
[TBL] [Abstract][Full Text] [Related]
50. Introduction to the special issue: timely detection of cervical cancer.
Robles SC
Bull Pan Am Health Organ; 1996 Dec; 30(4):285-9. PubMed ID: 9041739
[TBL] [Abstract][Full Text] [Related]
51. Variation in the cervical cancer screening compliance among women with disability.
Chen LS; Chou YJ; Tsay JH; Lee CH; Chou P; Huang N
J Med Screen; 2009; 16(2):85-90. PubMed ID: 19564521
[TBL] [Abstract][Full Text] [Related]
52. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
[TBL] [Abstract][Full Text] [Related]
53. A quasi-randomized trial on the effectiveness of an invitation letter to improve participation in a setting of opportunistic screening for cervical cancer.
de Jonge E; Cloes E; Op de Beeck L; Adriaens B; Lousbergh D; Orye GG; Buntinx F
Eur J Cancer Prev; 2008 Jun; 17(3):238-42. PubMed ID: 18414195
[TBL] [Abstract][Full Text] [Related]
54. Effectiveness of cervical cancer screening over cervical cancer mortality among Japanese women.
Aklimunnessa K; Mori M; Khan MM; Sakauchi F; Kubo T; Fujino Y; Suzuki S; Tokudome S; Tamakoshi A; ; Motohashi Y; Tsuji I; Nakamura Y; Iso H; Mikami H; Inaba Y; Hoshiyama Y; Suzuki H; Shimizu H; Toyoshima H; Wakai K; Ito Y; Hashimoto S; Kikuchi S; Koizumi A; Kawamura T; Watanabe Y; Miki T; Date C; Sakata K; Nose T; Hayakawa N; Yoshimura T; Shibata A; Okamoto N; Shino H; Ohno Y; Kitagawa T; Kuroki T; Tajima K
Jpn J Clin Oncol; 2006 Aug; 36(8):511-8. PubMed ID: 16844732
[TBL] [Abstract][Full Text] [Related]
55. Papanicolaou screening in developing countries: an idea whose time has come.
Suba EJ; Raab SS;
Am J Clin Pathol; 2004 Mar; 121(3):315-20. PubMed ID: 15023034
[TBL] [Abstract][Full Text] [Related]
56. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
57. Inadequacy of cervical cancer screening among urban recent immigrants: a population-based study of physician and laboratory claims in Toronto, Canada.
Lofters A; Glazier RH; Agha MM; Creatore MI; Moineddin R
Prev Med; 2007 Jun; 44(6):536-42. PubMed ID: 17467782
[TBL] [Abstract][Full Text] [Related]
58. Review of screening and preventive strategies for cervical cancer in India.
Patro BK; Nongkynrih B
Indian J Public Health; 2007; 51(4):216-21. PubMed ID: 18232160
[TBL] [Abstract][Full Text] [Related]
59. The cervical smear pattern in patients with chronic pelvic inflammatory disease.
Abdul MA; Shittu SO; Randawa JA; Shehu MS
Niger J Clin Pract; 2009 Sep; 12(3):289-93. PubMed ID: 19803028
[TBL] [Abstract][Full Text] [Related]
60. Adherence to cervical and breast cancer programs is crucial to improving screening performance.
Mauad EC; Nicolau SM; Moreira LF; Haikel RL; Longatto-Filho A; Baracat EC
Rural Remote Health; 2009; 9(3):1241. PubMed ID: 19778158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
